You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Claims for Patent: 7,776,366

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,776,366

Title:	Method and nutraceutical composition for mammals
Abstract:	A method is provided improving fertility in a mammal using glucosamine based composition. The composition is effective to improve fertility in mammals, including humans and stallions.
Inventor(s):	Davenport; David F. (Knoxville, TN), Martin; J. Eric (Louisville, TN)
Assignee:	MD\'s Choice, Inc. (Louisville, TN)
Application Number:	11/837,199
Patent Claims:	1. A method for improving fertility in a mammal in need of a conception, implantation, or gestation promoting treatment comprising administering to a mammal in need thereof a, conception, implantation, or gestation promoting effective amount of a nutraceutical composition comprising a glucosamine component in an effective proportion, wherein said glucosamine component is a chemical selected from the group consisting of glucosamine sulphate, glucosamine sulfate potassium chloride (glucosamine sulfate 2KCl, glucosamine sulfate sodium chloride (glucosamine sulfate NaCl, glucosamine hydrochloride, N-acetylglucosamine, Poly N-acetyl-glucosamine, and combinations thereof. 2. The method of claim 1, wherein the nutraceutical composition is in an oral liquid dosage form, or a powder form. 3. The method of claim 1, wherein the conception, implantation, or gestation promoting effective amount is a gametogenesis promoting effective amount. 4. The method of claim 3, wherein the nutraceutical composition comprises the following constituents: a) an oil cake component, b) the glucosamine component, c) an acid component, d) a mineral component, e) a vitamin component; and f) a functional food component, wherein each of the constituents is present in the composition in an effective proportion. 5. The method of claim 4, wherein said effective proportion further comprises: a) between about 50 and about 200 parts by weight (pbw) oil cake component, b) between about 400 to 750 pbw glucosamine component, c) between about 50 and about 150 pbw acid component, d) between about 0.0001 and about 1 pbw mineral component, e) between about 0.0001 and about 1 pbw vitamin component, and f) between about 0.0001 and about 1 pbw of functional food component. 6. The method of claim 5, wherein said acid component is ascorbic acid and at least one derivative thereof, lipoic acid, or dihydrolipoic acid, wherein the derivative is selected from the group consisting of magnesium ascorbyl phosphate, sodium ascorbyl phosphate, sodium ascorbate, ascorbyl glucoside, and combinations thereof. 7. The method of claim 6, wherein said mineral component further comprises at least one mineral selected from the group consisting of zinc, boron, chromium, manganese, and combinations thereof. 8. The method of claim 7, wherein said nutraceutical composition comprises an amino acid chelate. 9. The method of claim 8, wherein said vitamin component further comprises at least one vitamin selected from the group consisting of biotin, thiamine hydrochloride, folic acid, and combinations thereof. 10. The method of claim 9, wherein said functional food component further comprises at least one ingredient selected from the group consisting of prebiotic, probiotic, synbiotic, and combinations thereof. 11. The method of claim 10, wherein the oil cake component is selected from the group consisting of vegetable oil cake, soybean flower, linseed oil cake, cottonseed oil cake, peanut oil cake, safflower oil cake, coconut oil cake, palm oil cake, sesame oil cake, sunflower oil cake, rapeseed oil cake, kapok oil cake, mustard seed oil cake, and combinations thereof. 12. The method of claim 1, wherein said glucosamine component is a chemical selected from the group consisting of glucosamine sulphate, glucosamine sulfate 2KCl, glucosamine sulfate NaCl, and combinations thereof. 13. The method of claim 1, wherein said glucosamine component is a chemical selected from the group consisting of glucosamine sulphate, glucosamine sulfate 2KCl, and combinations thereof. 14. The method of claim 1, wherein said glucosamine component is glucosamine sulfate 2KCl. 15. The method of claim 1, further comprising identifying the mammal as needing a conception, implantation, or gestation promoting treatment. 16. The method of claim 1, wherein the mammal is a male. 17. The method of claim 1, wherein the mammal is a female.

Details for Patent 7,776,366

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Octapharma Pharmazeutika Produktionsges.m.b.h.	WILATE	von willebrand factor/coagulation factor viii complex (human)	For Injection	125251	December 20, 2010	⤷ Start Trial	2027-08-10
Aimmune Therapeutics, Inc.	PALFORZIA	peanut (arachis hypogaea) allergen powder-dnfp	Powder	125696	January 31, 2020	⤷ Start Trial	2027-08-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,776,366

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
United States of America	2004156923	⤷ Start Trial
United States of America	2008003302	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.